Comparison of the local effects of different intracameral cefuroxime solutions on rabbit cornea

Abstract Purpose We aimed to compare the local effects of intracameral cefuroxime diluted in normal saline (SF groups) against those of cefuroxime in balanced salt solution (BSS group) on the cornea of rabbits. Materials and methods Fourteen New Zealand albino rabbits were randomised into two groups. The right eyes of the rabbits in the SF group I were injected intracamerally with 1 mg cefuroxime diluted with 0.1 mL normal saline (n = 7), whereas the right eyes of the BSS group II were injected with 1 mg intracameral cefuroxime diluted with 0.1 mL with balance salt solution, and the left eyes of all rabbits received no treatment group III (control group). Corneal thickness was measured with pachymetry before and 1 week after the injection. Corneal samples were evaluated with light, specular and electron microscopy. Results Mean endothelial cell count was lower in the SF than in the BSS and control groups. Although an increase in corneal thickness was found in both treatment groups, this was not the case for the control group. The corneal endothelium preserved its hexagonal structure in all groups. Although both treatment groups showed a loss of endothelial microvilli, this was more prevalent in the SF group. However, microvilli were preserved in the control group. Dissolution of tight junctions in corneal endothelium was observed in the SF group only. Mitochondrial swelling, coarsening of endoplasmic reticulum, cytoplasmic vacuolisation, and increased endothelial cell sizes were the same in both treatment groups but was not observed in the control group. Thicker and more oedematous corneal stroma were observed in the SF group compared with the BSS and control groups. Conclusion Dilution of intracameral cefuroxime in BSS yielded superior results compared with dilution in normal saline owing to toxicity to the endothelial cells and decline in the endothelial cell number, resulting in intracellular and intercellular morphological changes. BSS or any other solution with proven safety should be used in clinical studies.

[1]  T. Greene,et al.  Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis , 2018, British Journal of Ophthalmology.

[2]  A. Grzybowski,et al.  The use of povidone–iodine in ophthalmology , 2018, Current opinion in ophthalmology.

[3]  D. Chang,et al.  Intracameral antibiotics during cataract surgery: evidence and barriers , 2018, Current opinion in ophthalmology.

[4]  D. Chang,et al.  Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. , 2017, Ophthalmology.

[5]  Sean Mathews,et al.  Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. , 2017, Journal of cataract and refractive surgery.

[6]  K. Ichihara,et al.  Incidence of endophthalmitis and the perioperative practices of cataract surgery in Japan: Japanese Prospective Multicenter Study for Postoperative Endophthalmitis after Cataract Surgery , 2017, Japanese Journal of Ophthalmology.

[7]  D. Chang,et al.  Intracameral antibiotics: Safety, efficacy, and preparation. , 2014, Journal of cataract and refractive surgery.

[8]  Q. Garrett,et al.  Decrease in hyperosmotic stress–induced corneal epithelial cell apoptosis by L-carnitine , 2013, Molecular vision.

[9]  D. Chang,et al.  Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis , 2011, Journal of cataract and refractive surgery.

[10]  C. Pang,et al.  In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications , 2011, Clinical & experimental ophthalmology.

[11]  G. Rodríguez-Caravaca,et al.  Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery: Ten‐year comparative study , 2010, Journal of cataract and refractive surgery.

[12]  Tök Y. Özlem,et al.  Are cefuroxime and vancomycin really safe on the corneal endothelial cells? , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  Jin A. Choi,et al.  Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[14]  K. Bartz-Schmidt,et al.  Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use , 2008, Journal of cataract and refractive surgery.

[15]  S. Masket,et al.  Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery , 2008, Journal of cataract and refractive surgery.

[16]  Arbisser Lb Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. , 2008 .

[17]  L. Arbisser Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery , 2008, Journal of cataract and refractive surgery.

[18]  Young-Hoon Park,et al.  Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells , 2008, Clinical & experimental ophthalmology.

[19]  P. Yu-Wai-Man,et al.  Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery , 2008, Journal of cataract and refractive surgery.

[20]  G. Gettinby,et al.  Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors , 2007, Journal of cataract and refractive surgery.

[21]  V. Caparas,et al.  Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients , 2007, Journal of cataract and refractive surgery.

[22]  H. Flynn,et al.  Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. , 2005, American journal of ophthalmology.

[23]  G. Koranyi,et al.  Prophylactic intracameral cefuroxime: Efficacy in preventing endophthalmitis after cataract surgery , 2002, Journal of cataract and refractive surgery.

[24]  C. Zetterström,et al.  Prophylactic intracameral cefuroxime: Evaluation of safety and kinetics in cataract surgery , 2002, Journal of cataract and refractive surgery.

[25]  T. Riordan,et al.  The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification , 1998, Eye.

[26]  D. Gritz,et al.  Antibiotic supplementation of intraocular irrigating solutions. An in vitro model of antibacterial action. , 1996, Ophthalmology.